Kyverna Therapeutics, Inc. (KYTX)
NASDAQ·Healthcare·Biotechnology
$7.11
-5.33%
Mkt Cap $433.47M
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (7 analysts)
$25.00
Range $25.00 – $25.00
Implied Upside
+251.9%
Consensus $25.00 vs current $7.11
NASDAQ·Healthcare·Biotechnology
$7.11
-5.33%
Mkt Cap $433.47M
Buy
4
Hold
0
Sell
0
Price Target (7 analysts)
$25.00
Range $25.00 – $25.00
+251.9%
Consensus $25.00 vs current $7.11